Your search returned 4 results.

Results
	1.	Bortezomib and ixazomib protect firefly luciferase from degradation and can flaw respective reporter gene assays. [electronic resource] by Becker, Jonas Philipp Clemens, Jannick Robert Theile, Dirk Weiss, Johanna Producer: 20170428 In: Analytical biochemistry vol. 509 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Bortezomib, carfilzomib and ixazomib do not mediate relevant transporter-based drug-drug interactions. [electronic resource] by Clemens, Jannick Welti, Lukas Schäfer, Julia Seckinger, Anja Burhenne, Jürgen Theile, Dirk Weiss, Johanna Publication details: Oncology letters Sep 2017 In: Oncology letters vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Stability of the proteasome inhibitor bortezomib in cell based assays determined by ultra-high performance liquid chromatography coupled to tandem mass spectrometry. [electronic resource] by Clemens, Jannick Longo, Magdalena Seckinger, Anja Hose, Dirk Haefeli, Walter Emil Weiss, Johanna Burhenne, Jürgen Producer: 20141014 In: Journal of chromatography. A vol. 1345 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters. [electronic resource] by Clemens, Jannick Seckinger, Anja Hose, Dirk Theile, Dirk Longo, Magdalena Haefeli, Walter Emil Burhenne, Jürgen Weiss, Johanna Producer: 20150331 In: Cancer chemotherapy and pharmacology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)